$HBIO News
Last published 1d ago
- 1d agoHBIOHARVARD BIOSCIENCE INC - EXHIBIT 99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1d agoHBIOHarvard Bioscience Announces Third Quarter 2026 Financial ResultsGlobeNewswire
- 1d agoHBIOQ3 2026 Harvard Bioscience, Inc. Earnings Conference Call - HARVARD BIOSCIENCE INCEarnings Call TranscriptsGood day, and welcome to the third quarter 2026 Harvard Bioscience Earnings Conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer
- 1d agoHBIOQ3 2026 Harvard Bioscience, Inc. Earnings Conference Call - HARVARD BIOSCIENCE INCEarnings Call TranscriptsGood day, and welcome to the third quarter 2026 Harvard Bioscience Earnings Conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer
- 1w agoHBIOHarvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services ForumGlobeNewswireHOLLISTON, Mass., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that John Duke, President and Chief Executive Officer, and Mark Frost, Chief Financial Officer, will
- 2w agoHBIOHarvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended September 30, 2026, before the market opens on November 10, 2026,
- 1mo agoHBIOHarvard Bioscience Announces Creation of Scientific Advisory BoardGlobeNewswireHOLLISTON, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced the creation of its Scientific Advisory Board (SAB) to guide the Company’s ongoing research, development, and
- 3mo agoHBIOQ2 2026 Harvard Bioscience, Inc. Earnings Conference Call - HARVARD BIOSCIENCE INCEarnings Call TranscriptsGood day, and welcome to the second quarter, 2026 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer
- 3mo agoHBIOQ2 2026 Harvard Bioscience, Inc. Earnings Conference Call - HARVARD BIOSCIENCE INCEarnings Call TranscriptsGood day, and welcome to the second quarter, 2026 Harvard Bioscience Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer
- 3mo agoHBIOHarvard Bioscience Announces Second Quarter 2026 Financial ResultsGlobeNewswireSecond Quarter 2026 Revenue Growth of 11% Year Over Year to $22.7 Million Raises Full Year 2026 Revenue Guidance to 3%-5% Year Over Year Growth HOLLISTON, Mass., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience,
- 3mo agoHBIOHarvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended June 30, 2026, before the market opens on August 11, 2026, and will
- 6mo agoHBIOQ1 2026 Harvard Bioscience, Inc. Earnings Conference CallHARVARD BIOSCIENCE INCEarnings Call TranscriptsGood day, and welcome to the Q1 2026 Harvard Biosciences, Inc. Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer sessi
- 6mo agoHBIOHarvard Bioscience Announces First Quarter 2026 Financial ResultsGlobeNewswireFirst Quarter 2026 Revenues of $20.8M and Gross Margin of 59%Consolidation of Manufacturing Operations Progressing on ScheduleReaffirms Full Year 2026 Financial Guidance HOLLISTON, Mass., May 12, 2026 (GLOBE
- 6mo agoHBIOHarvard Bioscience to Participate in Upcoming Investor ConferencesGlobeNewswireHOLLISTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced Chief Executive Officer, John Duke and Chief Financial Officer, Mark Frost's participation in the following
- 6mo agoHBIOHarvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended March 31, 2026, before the market opens on May 12, 2026, and will
- 8mo agoHBIOQ4 2025 Harvard Bioscience, Inc. Earnings Conference CallHARVARD BIOSCIENCE INCEarnings Call TranscriptsGood day, and welcome to the fourth quarter and full year 2025 Harvard Bioscience Earnings Conference call. All participants will be in a listen-only mode. After today's presentation, there will be a question-and-answer
- 8mo agoHBIOHarvard Bioscience Announces Reverse Stock SplitGlobeNewswireHarvard Bioscience's common stock is expected to begin trading on a post-split adjusted basis on March 16, 2026 HOLLISTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the
- 8mo agoHBIOHARVARD BIOSCIENCE, INC. SPECIAL MEETING OF STOCKHOLDERSHARVARD BIOSCIENCE INCEarnings Call TranscriptsGood morning, ladies and gentlemen. I am John Duke, President, CEO, and Director of Harvard Bioscience. I would like to welcome you all to this special meeting of stockholders, and thank you for your ongoing support of H
- 8mo agoHBIOHarvard Bioscience to Participate in KeyBanc's Virtual Healthcare ForumGlobeNewswireHOLLISTON, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that John Duke, President and Chief Executive Officer, and Mark Frost, Interim Chief Financial Officer, will
- 8mo agoHBIOHarvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended December 31, 2025, before the market opens on March 12, 2026, and
- 9mo agoHBIOHarvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus AreasGlobeNewswireReports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and mid-to
- 9mo agoHBIOHarvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term GrowthGlobeNewswireStreamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant Initiative expected to deliver approximately $3 million in cost savings in 2027 and $4 million in
- 10mo agoHBIOHarvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing PackageGlobeNewswireCompletes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial FlexibilityBroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and
- 1y agoHBIOHarvard Bioscience Announces Third Quarter 2025 Financial ResultsGlobeNewswireReports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by OperationsCompany Expects to Refinance or Repay the Debt in the Fourth QuarterFourth Quarter 2025 Guidance Reflects Increased
- 1y agoHBIOHarvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and
- 1y agoHBIOHarvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United StatesGlobeNewswireHOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), a leading provider of innovative laboratory equipment, is pleased to announce the
- 1y agoHBIOHarvard Bioscience Announces Appointment of Stephen DeNelsky to Board of DirectorsGlobeNewswireHOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced the appointment of Stephen DeNelsky to its Board of Directors,
- 1y agoHBIOHarvard Bioscience, Inc. (HBIO) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoHBIOHarvard Bioscience Announces Second Quarter 2025 Financial ResultsGlobeNewswireReports Q2 2025 Revenues of $20.5M, Gross Margin of 56.4%, and Positive Cash Provided by OperationsThird Quarter 2025 Guidance Reflects Improved Operations and Strong Financial DisciplineNew Credit Amendment Signed,
- 1y agoHBIOHarvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will
- 1y agoHBIOHarvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to BoardGlobeNewswireCurrent Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 '25 revenue anticipated to be $20.4 million and Company reiterates previously
- 1y agoHBIOHarvard Bioscience Appoints John Duke to Board of DirectorsGlobeNewswireHOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will
- 1y agoHBIOHarvard Bioscience Announces First Quarter 2025 Financial ResultsGlobeNewswireHOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced financial results for the first quarter ended March 31, 2025. Jim Green, Chairman and CEO,
- 1y agoHBIOHarvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold
- 1y agoHBIOHarvard Bioscience Announces CFO TransitionGlobeNewswireHOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced the resignation of Jennifer Cote, the Company's Chief Financial Officer and Treasurer. Ms.
- 1y agoHBIOHarvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025GlobeNewswireHOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will
- 1y agoHBIOHarvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial ResultsGlobeNewswireHOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2024. Jim Green,
- 1y agoHBIOHarvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology MeetingGlobeNewswireHOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology (SOT) conference from
- 1y agoHBIOHarvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended December 31, 2024, before the market opens on March 12, 2025, and
- 1y agoABLALCOAMSTAPOG+11Sidoti Events, LLC's Virtual January Micro-Cap ConferenceACCESS NewswireNEW YORK, NY / ACCESS Newswire / January 21, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking
- 1y agoHBIOHarvard Bioscience, Inc. to Participate in the Sidoti Micro Cap ConferenceGlobeNewswireHOLLISTON, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be
- 2y agoHBIOHarvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoHBIOHarvard Bioscience Announces Third Quarter 2024 Financial ResultsGlobeNewswireHOLLISTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced financial results for the third quarter ended September 30, 2024. Jim Green, Chairman and
- 2y agoHBIOHarvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ETGlobeNewswireHOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on November 7, 2024, and
- 2y agoHBIOHarvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024GlobeNewswireHOLLISTON, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) 2024 Annual
- 2y agoHBIOHarvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual MeetingGlobeNewswireHOLLISTON, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Safety Pharmacology Society (SPS) Annual
- 2y agoHBIOHarvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual ConferenceGlobeNewswireHOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be
- 2y agoHBIOHarvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoHBIOHarvard Bioscience Announces Second Quarter 2024 Financial ResultsGlobeNewswireHOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced financial results for the second quarter ended June 30, 2024. Jim Green, Chairman and CEO,
- 2y agoHBIOHarvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ETGlobeNewswireHOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) will announce its financial results for the quarter ended June 30, 2024 before the market opens on August 8, 2024, and will